| dc.contributor.author | Chopra, N | |
| dc.contributor.author | Turner, NC | |
| dc.date.accessioned | 2017-09-08T13:31:05Z | |
| dc.date.issued | 2017-07-01 | |
| dc.identifier.citation | The Lancet. Oncology, 2017, 18 (7), pp. 842 - 843 | |
| dc.identifier.issn | 1470-2045 | |
| dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/817 | |
| dc.identifier.eissn | 1474-5488 | |
| dc.identifier.doi | 10.1016/s1470-2045(17)30430-8 | |
| dc.format | Print-Electronic | |
| dc.format.extent | 842 - 843 | |
| dc.language | eng | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER SCIENCE INC | |
| dc.rights.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
| dc.subject | Humans | |
| dc.subject | Breast Neoplasms | |
| dc.subject | Mutation | |
| dc.subject | Phosphatidylinositol 3-Kinases | |
| dc.subject | Class I Phosphatidylinositol 3-Kinases | |
| dc.title | Targeting PIK3CA-mutant advanced breast cancer in the clinical setting. | |
| dc.type | Journal Article | |
| dcterms.dateAccepted | 2017-05-11 | |
| rioxxterms.funder | The Institute of Cancer Research | |
| rioxxterms.identifier.project | Unspecified | |
| rioxxterms.versionofrecord | 10.1016/s1470-2045(17)30430-8 | |
| rioxxterms.licenseref.uri | https://www.rioxx.net/licenses/all-rights-reserved | |
| rioxxterms.licenseref.startdate | 2017-07 | |
| rioxxterms.type | Journal Article/Review | |
| dc.relation.isPartOf | The Lancet. Oncology | |
| pubs.issue | 7 | |
| pubs.notes | Not known | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Molecular Oncology | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.organisational-group | /ICR | |
| pubs.organisational-group | /ICR/Primary Group | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research | |
| pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Breast Cancer Research/Molecular Oncology | |
| pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
| pubs.publication-status | Published | |
| pubs.volume | 18 | |
| pubs.embargo.terms | Not known | |
| icr.researchteam | Molecular Oncology | |
| dc.contributor.icrauthor | Turner, Nicholas | |
